Clinical Trial Update: A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating solifenacin succinate for improving urinary continence after robotic-assisted radical prostatectomy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• Solifenacin succinate (solifenacin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Incontinence | Phase 4 | Status: COMPLETED | Results posted: 2014-10-09